- Home
- MATH vs VANI Comparison
MATH vs VANI Comparison
Compare MATH & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATH
- VANI
- Stock Information
- Founded
- MATH 2015
- VANI 1998
- Country
- MATH Hong Kong
- VANI United States
- Employees
- MATH N/A
- VANI N/A
- Industry
- MATH Finance/Investors Services
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MATH Finance
- VANI Health Care
- Exchange
- MATH Nasdaq
- VANI Nasdaq
- Market Cap
- MATH 60.8M
- VANI 68.1M
- IPO Year
- MATH N/A
- VANI 2014
- Fundamental
- Price
- MATH $3.30
- VANI $1.15
- Analyst Decision
- MATH
- VANI Strong Buy
- Analyst Count
- MATH 0
- VANI 1
- Target Price
- MATH N/A
- VANI $4.00
- AVG Volume (30 Days)
- MATH 346.2K
- VANI 136.2K
- Earning Date
- MATH 01-01-0001
- VANI 08-12-2025
- Dividend Yield
- MATH N/A
- VANI N/A
- EPS Growth
- MATH N/A
- VANI N/A
- EPS
- MATH 0.17
- VANI N/A
- Revenue
- MATH $31,399,049.00
- VANI N/A
- Revenue This Year
- MATH N/A
- VANI N/A
- Revenue Next Year
- MATH N/A
- VANI N/A
- P/E Ratio
- MATH $20.38
- VANI N/A
- Revenue Growth
- MATH 291.58
- VANI N/A
- 52 Week Low
- MATH $0.80
- VANI $0.91
- 52 Week High
- MATH $4.17
- VANI $1.50
- Technical
- Relative Strength Index (RSI)
- MATH 51.81
- VANI 54.56
- Support Level
- MATH $2.72
- VANI $1.13
- Resistance Level
- MATH $4.17
- VANI $1.25
- Average True Range (ATR)
- MATH 0.39
- VANI 0.05
- MACD
- MATH -0.11
- VANI -0.01
- Stochastic Oscillator
- MATH 34.83
- VANI 29.05
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.